Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | Patent Number 11780911

US 11780911 B2
Application Number16880118
Publication NumberUS 20200369761 A1
Pendency3 years, 4 months, 22 days
Filled DateMay 21, 2020
Priority DateMay 23, 2019
Publication DateNov 26, 2020
Expiration DateMay 22, 2039
Inventor/ApplicantsMatthew Germinaro
Christopher O'Brien
Jacqueline Perrigoue
Mathew Germinaro
ExaminesHAMUD, FOZIA M
Art Unit1647
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.